alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
309.404 System for Award Management (SAM) exclusions. ( c ) For actions made by HHS pursuant to FAR 9.406 and 9.407, the Office of Recipient Integrity Coordination shall perform the actions required by FAR 9.404(c).
#### 3052.223-70 Removal or disposal of hazardous substances—applicable licenses and permits.

As prescribed in (HSAR) 48 CFR 3023.303, insert the following clause:

# Removal or Disposal of Hazardous Substances—Applicable Licenses and Permits (JUN 2006)

The Contractor shall have all licenses and permits required by Federal, state, and local laws to perform hazardous substance(s) removal or disposal services. If the Contractor does not currently possess these documents, it shall obtain all requisite licenses and permits within _[“insert days”]_ days after date of award. The Contractor shall provide evidence of said documents to the Contracting Officer or designated Government representative prior to commencement of work under the contract.

(End of clause)

[71 FR 25775, May 2, 2006]
#### Columbia Interconnect Associates, Inc., Appellant-Respondent, v Tele/Resources, Inc., Respondent-Appellant.

— In an action to recover damages for breach of contract (1) plaintiff appeals, as limited by its brief, from so much of an order of the Supreme Court, Westchester County, entered January 19, 1978, as granted defendant summary judgment dismissing plaintiff’s first cause of action and a portion of plaintiff’s second cause of action, and (2) defendant cross-appeals from so much of the same order as denied its motion for summary judgment as to certain portions of plaintiff’s second cause of action. Order modified, on the law, by adding thereto a provision striking defendant’s first affirmative defense to the second cause of action. As so modified, order affirmed, without costs or disbursements. The *675defendant asserts as an affirmative defense to each of the two causes of action that the corporate plaintiff was not in existence on the date of the contract. It appears from the undisputed facts that plaintiff adopted the agreement by its actions in furtherance of the performance thereof. Hence, the agreement was enforceable by it and defendant’s affirmative defense in this regard should be stricken (cf. *S & B Rubber & Chem. Corp. v Stein,*7 NYS2d 553, affd 255 App Div 1012; see, also, *Ehrlich v Drake Constr. Corp.,*92 NYS2d 711). Hopkins, J. P., Damiani, Titone and O’Connor, JJ., concur.
**Exhibit 32.1 — ****Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002**In connection with the Annual Report of First Financial Corporation (the “Corporation”) onForm 10-K for the year ended December 31, 2007 as filed with the Securities and Exchange Commissionon the date hereof (the “Report”), I, Norman L. Lowery, Vice Chairman and CEO of the Corporation,certify, pursuant to 18 U.S.C. section 1350, as adopted pursuant to section 906 of theSarbanes-Oxley Act of 2002, that: (1) the Report fully complies with the requirements of section 13(a) or 15(d) of theSecurities Exchange Act of 1934; and  (2) the information contained in the Report fairly presents, in all material respects, thefinancial condition and results of operations of the Corporation.This certification is furnished solely pursuant to 18 U.S.C. section 1350 and is not being filedfor any other purpose.   Date: March 12, 2008     /s/ Norman L. Lowery     Norman L. Lowery
#### 352.270-5a Notice to Offerors of Requirement for Compliance with the Public Health Service Policy on Humane Care and Use of Laboratory Animals.

As prescribed in HHSAR 370.403(a), the Contracting Officer shall insert the following provision:

# Notice to Offerors of Requirement for Compliance with the Public Health Service Policy on Humane Care and Use of Laboratory Animals (DEC 2015)

The Public Health Service (PHS) Policy on Humane Care and Use of Laboratory Animals (PHS Policy) establishes a number of requirements for research activities involving animals. Before awarding a contract to an offeror, the organization shall file, with the Office of Laboratory Animal Welfare (OLAW), National Institutes of Health (NIH), a written Animal Welfare Assurance (Assurance) which commits the organization to comply with the provisions of the PHS Policy, the Animal Welfare Act, and the Guide for the Care and Use of Laboratory Animals (National Academy Press, Washington, DC). In accordance with the PHS Policy, offerors must establish an Institutional Animal Care and Use Committee (IACUC), qualified through the experience and expertise of its members, to oversee the institution's animal program, facilities, and procedures. Offerors must provide verification of IACUC approval prior to receiving an award involving live vertebrate animals. No award involving the use of animals shall be made unless OLAW approves the Assurance and verification of IACUC approval for the proposed animal activities has been provided to the Contracting Officer. Prior to award, the Contracting Officer will notify Contractor(s) selected for projects involving live vertebrate animals of the Assurance and verification of IACUC approval requirement. The Contracting Officer will request that OLAW negotiate an acceptable Assurance with those Contractor(s) and request verification of IACUC approval. For further information, contact OLAW at NIH, 6705 Rockledge Drive, RKL1, Suite 360, MSC 7982 Bethesda, Maryland 20892-7982 (Email: *olaw@od.nih.gov*; Phone: 301-496-7163).

(End of provision)
32.412 Contract clause. ( a ) The contracting officer shall insert the clause at 52.232-12, Advance Payments, in solicitations and contracts under which the Government will provide advance payments, except as provided in 32.412(b).
( b ) If the agency desires to waive the countersignature requirement because of the contractor's financial strength, good performance record, and favorable experience concerning cost disallowances, the contracting officer shall use the clause with its *Alternate I.*
( c ) If a cost-reimbursement contract is contemplated, the contracting officer shall use the clause with its *Alternate II.*
( d ) If the agency considers a more rapid liquidation appropriate, the contracting officer shall use the clause with its *Alternate III.*
( e ) If the agency provides advance payments under the contract at no interest to the prime contractor, the contracting officer shall use the clause with its *Alternate IV.*
( f ) If the requirement for a special account is eliminated in accordance with 32.409-3 (e) or (g), the contracting officer shall insert in the solicitation or contract the clause set forth in *Alternate V* of 52.232-12, Advance Payments, instead of the basic clause.
[48 FR 42328, Sept. 19, 1983, as amended at 55 FR 25530, June 21, 1990; 66 FR 2138, Jan. 10, 2001]
exv10w5






Exhibit 10.5




SLM Corporation Directors Equity Plan

Non-Employee Director Restricted Stock Agreement

2009




               Pursuant to the terms and conditions of the SLM Corporation Directors Equity Plan (“the
Plan”), the Board of Directors of SLM Corporation (the “Corporation”) hereby grants to
«Name» (the “Grantee”)
___ shares of common stock of the Corporation, par value $0.20,
(“Restricted Stock”) on May ___, 2009 (“Grant Date”) subject to the terms and conditions below.
All capitalized terms used herein that are not defined shall have the meanings as set forth in the
Plan.




	 	•	 	100 percent of the Restricted Stock is subject to a risk of forfeiture and is
non-transferable until the moment immediately prior to the Corporation’s 2010 annual
shareholder meeting, and at that moment, 100 percent of the Restricted Stock will vest and
become transferable unless vested earlier as set forth below.
	 
	 	•	 	The Restricted Stock will vest and be transferable earlier than the moment immediately
prior to the Corporation’s 2010 annual shareholder meeting upon any of the following
events: (i) the Grantee’s death or Disability or (ii) upon Change of Control or a Change of
Control Transaction.
	 
	 	•	 	If the Grantee leaves the service of the Board of Directors prior to the Corporation’s
2010 annual shareholder meeting for reasons other than: death, Disability (as defined
herein) or a Change of Control or Change of Control Transaction, then 100 percent of the
Restricted Stock will be forfeited.
	 
	 	•	 	The Restricted Stock will be held in an account in the Grantee’s name at the
Corporation’s transfer agent, currently Computershare. The Grantee is entitled to vote the shares of Restricted Stock.
	 
	 	•	 	Dividends declared on unvested shares of Restricted Stock will not be paid currently.
Instead, amounts equal to such dividends will be credited to an account established on
behalf of the Grantee and such amounts will be deemed to be invested in additional shares
of SLM common stock (“Dividend Equivalents”). Such Dividend Equivalents will be subject to
the same vesting schedule to which the Restricted Stock is subject. At the time that the
underlying Restricted Stock vests, the amount of Dividend Equivalents allocable to such
Restricted Stock (and any fractional share amount) will also vest and will be payable to
the Grantee in shares of SLM common stock. Dividend Equivalents are not subject to income
tax until vesting, at which time they are taxed as ordinary income.
	 
	 	•	 	“Disability” means the absence of the Grantee from Board of Director’s duties with the
Company for 180 consecutive days as a result of incapacity due to mental or physical
illness which is determined to be total and permanent by a physician selected by the
Corporation or its insurers and reasonably acceptable to the Grantee or the Grantee’s legal
representative.





	 	 	 	 	 
	 
	 	 	 	 
	 

	 	 

Signature:           «Name»
	 	 
	 
	 	 	 	 
	 

	 	 

Date
	 	 






	 	 	 	 	 
	SLM CORPORATION	 	 
	 
	 	 	 	 
	
	 	 
	 
	BY:

	 	 

Albert L. Lord
	 	 
	 

	 	Chief Executive Officer
219.401 General. ( b ) The contracting activity small business specialist is the primary activity focal point for interface with the SBA.
# A Protocol to Identify Flowback Water Contamination to Drinking

Waters Don Siegel (Syracuse University) Melody Kight, Esq. (SUNY - ESF)Marcellus

# The Fundamental Issue • False Positives It is! It is not..

# Typical Marcellus Flowback

0.01 0.1 1 10 100 1000 10000 100000 mg/L SO4 Cl NaFrom Tetratech, 2010 

# False PositiveFe, Mn Organics Base Cations Halogens and Water Flow Direction

# Salinity: other sources

• Road salt • Septic discharge • Formation brine • Water softeners1.E -02 1.E -01 1.E+00 1.E+01 1.E+02 1.E+03 1.E+04

1.E -02 1.E -01 1.E+00 1.E+01 1.E+02 1.E+03 1.E+04 [Na] (meq/L) [Cl] (meq/L) Sodium and Chloride Poor Forensic Tool GROUNDWATER GW + ROAD SALT GW + SEPTIC BRINES FLOWBACK0.01 0.10 1.00 10.00
1.E+00 1.E+01 1.E+02 1.E+03 1.E+04 1.E+05 [Na/Cl] (mg/L) [Cl] (mg/L)

GW + ROAD SALT BRINE FLOWBACK GROUNDWATER GW + SEPTIC0.00 0.01 0.10 1.00 10.00
1.E+00 1.E+01 1.E+02 1.E+03 1.E+04 1.E+05 [Ca/Cl] (mg/L) [Cl] (mg/L) GROUNDWATER GW + SEPTIC GW + ROAD SALT BRINE

FLOWBACKHalite Precipitation Bromide Remains in Brine Carpenter, 1978 

### Halite ---very low Br/CL Brines—higher Br/Cl0

1000 2000 3000 4000 5000 6000 7000 8000

0 10 20 30 40 50 60 70 80 Chloride (mmol/kg water) Bromide (mmol/kg water) APPALACHIAN SEAWATER EVAPORATION LINE Original Brine Halite Dissolution1.00E -04 1.00E -03 1.00E -02 1.00E -01

1.E+01 1.E+02 1.E+03 1.E+04 1.E+05 [Br/Cl] (mg/L) [Cl] (mg/L) GW + ROAD SALT GW + SEPTIC BRINE FLOWBACKTownsend and Whittimore, 20050.000001

0.00001 0.0001 0.001 0.01 0.1 1 10 100 1000 10000

0 0.001 0.002 0.003 0.004 0.005 0.006 % Brine in Mixturee or Cl (mg/L) Br/Cl (mg/mg) % Brine Cl (mg/L)MDL Br 0.001 0.01 0.1 1 10 100 0 0.0005 0.001 0.0015 0.002 Concentration (mg/L) Brine in Mixture (%) Chloride Bromide

# Site Specific • Flowback variability • Background • Simple and clean forensics • Working on other halogens and isotopic and 

# chemical characterization of fugitive gas
<PAGE>
                                   EXHIBIT 23

                       CONSENT OF INDEPENDENT ACCOUNTANTS

We hereby consent to the incorporation by reference in the Registration
Statements on Form S-3 (Nos. 33-51639 and 333-71695) and in the Registration
Statements on Form S-8 (Nos. 33-63013, 33-71647, 33-37312, 33-69174, 33-63015,
333-42887, 333-70701, 333-53598 and 333-81668) of Biogen, Inc. of our report
dated January 17, 2002 relating to the financial statements, which appears in
the Annual Report to Shareholders, which is incorporated in this Annual Report
on Form 10-K. We also consent to the incorporation by reference of our report
dated January 17, 2002 relating to the financial statement schedule, which
appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

Boston, Massachusetts
March 29, 2002
#### 252.234-7004 Cost and Software Data Reporting System.

*Basic.* As prescribed in 234.7101(b) and (b)(1), use the following clause:

# Cost and Software Data Reporting System—Basic (NOV 2014)

(a) In the performance of this contract, the Contractor shall use—

(1) A documented standard cost and software data reporting (CSDR) process that satisfies the guidelines contained in the DoD 5000.04-M-1, CSDR Manual;

(2) Management procedures that provide for generation of timely and reliable information for the contractor cost data reports (CCDRs) and software resources data reports (SRDRs) required by the CCDR and SRDR data items of this contract; and

(3) The Government-approved CSDR plan for this contract, DD Form 2794, and the related Resource Distribution Table as the basis for reporting in accordance with the required CSDR data item descriptions.

(b) The Contractor shall require CSDR reporting from subcontractors at any tier with a subcontract that exceeds $50 million. If, for subcontracts that exceed $50 million, the Contractor changes subcontractors or makes new subcontract awards, the Contractor shall notify the Government.

(End of clause)

*Alternate I.* As prescribed in 234.7101(b) and (b)(2), use the following clause, which uses a different paragraph (b) than the basic clause:

# Cost and Software Data Reporting System—Alternate I (NOV 2014)

(a) In the performance of this contract, the Contractor shall use—

(1) A documented standard cost and software data reporting (CSDR) process that satisfies the guidelines contained in the DoD 5000.04-M-1, CSDR Manual;

(2) Management procedures that provide for generation of timely and reliable information for the contractor cost data reports (CCDRs) and software resources data reports (SRDRs) required by the CCDR and SRDR data items of this contract; and

(3) The Government-approved CSDR plan for this contract, DD Form 2794, and the related Resource Distribution Table as the basis for reporting in accordance with the required CSDR data item descriptions (DIDs).

(b) The Contractor shall require CSDR reporting from selected subcontractors identified in the CSDR contract plan as requiring such reporting. If the Contractor changes subcontractors or makes new awards for selected subcontract effort, the Contractor shall notify the Government.

(End of clause)

[75 FR 71562, Nov. 24, 2010, as amended at 79 FR 65594, Nov. 5, 2014; 80 FR 36900, June 26, 2015]
Amendment to the Briggs & Stratton Corporation Key Employee Savings



 Exhibit 10.15 
 BRIGGS & STRATTON CORPORATION 
 FORM 10-Q for
Quarterly Period Ended September 27, 2009 
 Exhibit 10.15 
 AMENDMENT TO THE BRIGGS & STRATTON CORPORATION 
 KEY
EMPLOYEE SAVINGS AND INVESTMENT PLAN 
 Adopted by the Board of Directors on October 21, 2009 







 FURTHER RESOLVED, that Section 4.1 of the Briggs & Stratton
Corporation Key Employee Savings and Investment Plan is hereby amended to read as follows: 
 “4.1 Employee Matching
Contributions Amount. 
 (a) For each pay period the Employer shall credit to each Participant’s Employer Matching
Contribution Account an amount equal to 50% of the Participant’s Deferral Contributions under Sections 3.1 and 3.2 above, for such pay period; provided, however, that the total Employer Matching Contributions for any pay period shall be limited
so that they do not exceed (i) 3.5% of the Regular Compensation and Total Bonus Payout of the Participant for such pay period minus (ii) an amount equal to (A) times (B) where (A) is 3.5% and (B) is the
Participant’s Regular Compensation and Total Bonus Payout for such pay period minus the amount of his Deferred Contributions under Article III for such pay period. The offset under clause (ii) of the preceding sentence shall cease to be
applied in pay periods after the cumulative amount of the Participant’s Regular Compensation and Total Bonus Payout minus the amount of his Deferral Contributions under Article III for the Plan Year equals the dollar amount described in
Internal Revenue Code Section 401(a)(17), as adjusted for cost of living increases. If the dollar limitation under Section 401(a)(17) is adjusted during the Plan Year, the offsets under clause (ii) above shall be resumed if necessary
so that the total amount of the offsets under clause (ii) above equal 3.5% of the limitation under Code Section 401(a)(17) as in effect at the end of the Plan Year or, if less, 3.5% of the Participant’s Regular Compensation and Total
Bonus Payout for the Plan Year minus the amount of his Deferral Contributions under Article III for the Plan Year. 
 (b)
Notwithstanding paragraph (a) above, no Employer Matching Contributions shall be made pursuant to this Section 4.1 with respect to any period of time after June 30, 2009. 
 (c) The preceding paragraph (b) shall cease to be of any applicability for Plan Years beginning after December 31, 2009.”

 FURTHER RESOLVED, that the appropriate officers of this Corporation are hereby authorized and directed to take any and all such further
actions as they deem necessary or desirable in order to implement the foregoing resolutions.
**Program Office:**Institutional Service

**CFDA Number:** 84.116D**Program Type:** Discretionary/Competitive Grants**Also Known As:**  NCITSPSD; the Center

## Program Description

This program supports a National Center for Information and Technical Support for Postsecondary Students with Disabilities (the Center) to provide technical assistance and information on best and promising practices for students with disabilities as they transition to, or attend, postsecondary education.

Institutions of higher education, as well as elementary and secondary schools, have legal obligations under two civil rights laws prohibiting disability discrimination, section 504 of the Rehabilitation Act of 1973 (29 U.S.C. 794) and the Americans with Disabilities Act of 1990 (ADA) (42 U.S.C. 12101-12213).  The technical assistance and information provided by the Center can help students, parents, and educational officials in determining how to meet these obligations and ensure the rights of students with disabilities.

In particular, the Center can assist students with disabilities and their families in understanding that in institutions of higher education, students with disabilities do not have the same rights and protections they had in secondary school under section 504 and the Individuals with Disabilities Education Act (IDEA), 20 U.S.C. 1400 et seq., for eligible children with disabilities.  Students with disabilities and their parents need to understand the differences in these rights and responsibilities as they enter college and pursue postsecondary education.  Specifically, unlike students in secondary school, postsecondary students are responsible for requesting the academic adjustments, auxiliary aids and services, and other accommodations they need in order to succeed, and are expected to comply with reasonable requirements that an institution of higher education may have concerning documentation of disability and the need for accommodations under section 504 and the ADA.
# C_2017398EN.01000201.xml

| 24.11.2017 | EN | Official Journal of the European Union | C 398/2 |
| --- | --- | --- | --- |

24.11.2017

EN

Official Journal of the European Union

C 398/2

---

Euro exchange rates (1)

1

23 November 2017

(2017/C 398/03)

1 euro =

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,1848 |
| JPY | Japanese yen | 131,79 |
| DKK | Danish krone | 7,4420 |
| GBP | Pound sterling | 0,89005 |
| SEK | Swedish krona | 9,8440 |
| CHF | Swiss franc | 1,1613 |
| ISK | Iceland króna | |
| NOK | Norwegian krone | 9,6393 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 25,462 |
| HUF | Hungarian forint | 313,05 |
| PLN | Polish zloty | 4,2124 |
| RON | Romanian leu | 4,6522 |
| TRY | Turkish lira | 4,6420 |
| AUD | Australian dollar | 1,5532 |
| CAD | Canadian dollar | 1,5024 |
| HKD | Hong Kong dollar | 9,2528 |
| NZD | New Zealand dollar | 1,7198 |
| SGD | Singapore dollar | 1,5947 |
| KRW | South Korean won | 1 284,55 |
| ZAR | South African rand | 16,4406 |
| CNY | Chinese yuan renminbi | 7,7881 |
| HRK | Croatian kuna | 7,5778 |
| IDR | Indonesian rupiah | 15 973,47 |
| MYR | Malaysian ringgit | 4,8674 |
| PHP | Philippine peso | 59,869 |
| RUB | Russian rouble | 69,2337 |
| THB | Thai baht | 38,713 |
| BRL | Brazilian real | 3,8403 |
| MXN | Mexican peso | 22,0927 |
| INR | Indian rupee | 76,5120 |

Currency

Exchange rate

USD

US dollar

1,1848

JPY

Japanese yen

131,79

DKK

Danish krone

7,4420

GBP

Pound sterling

0,89005

SEK

Swedish krona

9,8440

CHF

Swiss franc

1,1613

ISK

Iceland króna

NOK

Norwegian krone

9,6393

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

25,462

HUF

Hungarian forint

313,05

PLN

Polish zloty

4,2124

RON

Romanian leu

4,6522

TRY

Turkish lira

4,6420

AUD

Australian dollar

1,5532

CAD

Canadian dollar

1,5024

HKD

Hong Kong dollar

9,2528

NZD

New Zealand dollar

1,7198

SGD

Singapore dollar

1,5947

KRW

South Korean won

1 284,55

ZAR

South African rand

16,4406

CNY

Chinese yuan renminbi

7,7881

HRK

Croatian kuna

7,5778

IDR

Indonesian rupiah

15 973,47

MYR

Malaysian ringgit

4,8674

PHP

Philippine peso

59,869

RUB

Russian rouble

69,2337

THB

Thai baht

38,713

BRL

Brazilian real

3,8403

MXN

Mexican peso

22,0927

INR

Indian rupee

76,5120

---

(1)  Source: reference exchange rate published by the ECB.

1

Source

---
#### 252.209-7005 [Reserved]